Human paraoxonase‐1 (PON1) is a high‐density lipoprotein‐associated enzyme with antioxidant, anti‐inflammatory, and antiapoptotic roles. The ability of PON1 to hydrolyze specific organophosphate (OP) compounds and prevent accumulation of oxidized lipids in lipoproteins has prompted a large number of studies investigating PON1's role in modulating toxicity and disease. Most of these studies, however, have only focused on
This article was corrected on 18 July 2022. See the end of the full text for details.